3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Hyperinsulinemia: new trials by email Literature Review of Hyperinsulinemia trials Research Report on Hyperinsulinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β Anakinra, Placebo - Hyperinsulinemia, PreDiabetes | Phase 2 | Completed | University Hospital, Basel, Switzerland | 20 | 2023-06-15 | 2025-01-29 |
| EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance metformin and rosiglitazone - Hyperinsulinemia, Insulin Resistance | Phase 2 | Completed | New York Medical College | 46 | 2008-01-01 | 2014-03-28 |
| Metformin to Treat Obesity in Children With Insulin Resistance Metformin HCL, Placebo - Hyperinsulinemia, Obesity | Phase 2 | Completed | Jack Yanovski, M.D. | 100 | 2000-05-01 | 2015-05-08 |
Hyperinsulinism (3) · Obesity (2) · Diabetes Mellitus (1) · Dyslipidemias (1) · Insulin Resistance (1) · Overweight (1) · Pediatric Obesity (1) · Prediabetic State (1)
Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Body Weight (2) · Endocrine System Diseases (2) · Nutrition Disorders (2) · Overnutrition (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Diabetes Mellitus (1) · Lipid Metabolism Disorders (1) · Overweight (1)
Metformin (2) · Interleukin 1 Receptor Antagonist Protein (1) · Rosiglitazone (1) · rosiglitazone-metformin combination (1)
Jack Yanovski, M.D. (1) · New York Medical College (1) · University Hospital, Basel, Switzerland (1)
United States (2) · Switzerland (1)
Harriette R Mogul, MD MPH (1) · Jack A Yanovski, MD, PhD (1) · Marc Donath, Prof. (1)
PMID 21228310, PMID 25259787, PMID 25483291, PMID 26789348, PMID 29718281, PMID 38271099
2023 (1)